title: Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
authors.affiliation: Irmandade da Santa Casa de Misericórdia de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. diegognatta@yahoo.com.br
authors.forename: D
authors.initials: D
authors.lastname: Gnatta
authors.forename: E
authors.initials: E
authors.lastname: Keitel
authors.forename: I
authors.initials: I
authors.lastname: Heineck
authors.forename: B D
authors.initials: BD
authors.lastname: Cardoso
authors.forename: A P
authors.initials: AP
authors.lastname: Rodrigues
authors.forename: K
authors.initials: K
authors.lastname: Michel
authors.forename: V D
authors.initials: VD
authors.lastname: Garcia
mesh_terms: D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects*; D019520:Living Donors / Q000706:statistics & numerical data; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology / Q000276:immunology; D012189:Retrospective Studies; D012307:Risk Factors; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use; D014019:Tissue Donors / Q000706:statistics & numerical data
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus; D016559:Tacrolimus